{
  "docId": "019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "docSlug": "6ded4b1cfe2c",
  "documentTitle": "Bristol-Myers Squibb Company (BMY)",
  "authorId": "03_Starboard_Value",
  "authorName": "Starboard Value",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2019-03-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 113,
  "pageCount": 197,
  "prevPage": 112,
  "nextPage": 114,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Uses screenshots of news articles as evidence of public and regulatory sentiment.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "screenshot",
    "callout_box",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6d9-fc4318e06f9b/113",
  "deckHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b#slide-113",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.38,
        "x": 0.58,
        "y": 0.23
      },
      "kind": "callout",
      "text": "Potential CAR-T Risks",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "863f9139-25cc-4052-bab1-75b24b07a54a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Given today's drug pricing environment, we believe that CAR-T pricing will remain a headwind",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0f19-73dd-8e9b-6ff4f60a33b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.62,
        "w": 0.53,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "image",
      "text": "Screenshots of news headlines regarding CAR-T pricing",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2744654f-f54a-45c8-8c39-d43f516131d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.58,
        "y": 0.31
      },
      "kind": "list",
      "text": "There is already increasing government concern and media coverage of CAR-T pricing, indicating that many believe the price is too high. In addition, several leading industry consultants that we have spoken with believe that a significant increase in affordability can only be achieved with industrial-scale manufacturing – a feat that current technologies are incapable of achieving.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "669a8f83-7a90-4fee-9c2d-93a68077c8d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "CAR-T therapy pricing has already generated negative media headlines while reimbursement has been rejected in certain geographies.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d388229-4b5c-4826-856f-2381bb060f04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "UK rejects Gilead's CAR-T cancer cell therapy as too expensive — Ben Hirschler. Patient Advocate Says Novartis' $475,000 Breakthrough Should Cost Just $160,000 — Matthew Herper",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0f19-73dd-8e9b-729f91093ba1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.01,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: News reports, industry research and interviews.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d315f0a4-0c99-48b3-897f-c98ad77fb18f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.89
      },
      "kind": "title",
      "text": "Given today's drug pricing environment, we believe that CAR-T pricing will remain a headwind",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4515ad97-eb1e-4d66-bcf5-076618b510e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "Pricing and Reimbursement for CAR-T Products Could Also Be Challenging",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50fe37b7-0bd1-4803-a933-069b08dfae71",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "7f4600e4-bee2-4e5a-ad33-041824dcda1a",
      "evidence": "Uses news headlines and industry consultant opinions to validate the pricing headwind argument.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}